{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:41:42Z","timestamp":1774046502577,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870988, 82001335, 82071410"],"award-info":[{"award-number":["81870988, 82001335, 82071410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["20dz2260100"],"award-info":[{"award-number":["20dz2260100"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients with myasthenia gravis (MG) are prone to the development of pneumonia due to the long-term immunotherapies they receive and a tendency for aspiration. Pneumonia remains a risk factor for MG worsening and is the most prevalent cause of mortality in MG patients. Classification of the pathogens involved and exploration of the risk factors for mechanical ventilation (MV) could aid in improving clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between January 2013 and October 2022, we performed an inpatient database review for MG patients with pneumonia concurrence in a tertiary research center specializing in neuromuscular disorders. The clinical and microbiological characteristics of 116 MG patients with pneumonia were retrospectively analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In our cohort, 90.32% (112\/124) of organisms were bacteria and 42.86% (48\/112) of pathogenic bacteria were carbapenem-resistant. A high abundance of Epstein\u2013Barr virus (EBV) was detected using next-generation sequencing (NGS) in 12 patients, while cytomegalovirus (CMV) was detected in 8 patients. Non-fermentative Gram-negative bacilli were the most prevalent microorganisms, in which ampicillin, sulfamethoxazole-trimethoprim (SMZ-TMP), piperacillin, cefoperazone, ceftazidime, and cefepime may have an anti-infectious effect. Moreover, peripheral lymphocyte percentage [odds ratio (OR) 0.88, 95% CI 0.75\u20130.96, <jats:italic>p<\/jats:italic> = 0.02] and serum globulin (OR 1.16, 95% CI 1.02\u20131.35, <jats:italic>p<\/jats:italic> = 0.03) were significantly associated with the risk of MV demand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our identification of the microbial etiology of pneumonia in MG patients may provide future perspectives on accurate antibiotic options and enable early interventions when risk factors are present.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.1016728","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T07:45:31Z","timestamp":1670571931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Pneumonia in myasthenia gravis: Microbial etiology and clinical management"],"prefix":"10.3389","volume":"12","author":[{"given":"Manqiqige","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1080\/22221751.2020.1807411","article-title":"Precise diagnosis of neisseria macacae infective endocarditis assisted by nanopore sequencing","volume":"9","author":"Ai","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jinf.2017.11.002","article-title":"Dynamic and direct pathogen load surveillance to monitor disease progression and therapeutic efficacy in central nervous system infection using a novel semi-quantitive sequencing platform","volume":"76","author":"Ai","year":"2018","journal-title":"J. Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1080\/22221751.2019.1664939","article-title":"CRISPR-based rapid and ultra-sensitive diagnostic test for mycobacterium tuberculosis","volume":"8","author":"Ai","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SMJ.0b013e31815d4398","article-title":"Myasthenia gravis crisis","volume":"101","author":"Bershad","year":"2008","journal-title":"South Med. J."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2020.100063","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Reg. Health West Pac."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00281","article-title":"Tracking carbapenem-producing klebsiella pneumoniae outbreak in an intensive care unit by whole genome sequencing","volume":"9","author":"Chen","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B7","volume-title":"Accquired autoimmune myasthenia gravis","author":"Engel","year":"1994"},{"key":"B8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13760-021-01612-6","article-title":"Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay","volume":"121","author":"Galassi","year":"2021","journal-title":"Acta Neurol. Belg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1177\/0961203318799207","article-title":"Pneumonia in patients with systemic lupus erythematosus: Epidemiology, microbiology and outcomes","volume":"27","author":"Garcia-Guevara","year":"2018","journal-title":"Lupus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/mus.26689","article-title":"Factors associated with acute exacerbations of myasthenia gravis","volume":"60","author":"Gummi","year":"2019","journal-title":"Muscle Nerve"},{"key":"B11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: Classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol. Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.10378","article-title":"Maximal voluntary ventilation in myasthenia gravis","volume":"27","author":"Heliopoulos","year":"2003","journal-title":"Muscle Nerve"},{"key":"B13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"Jakubikova","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2165\/11593110-000000000-00000","article-title":"Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review","volume":"34","author":"Jones","year":"2011","journal-title":"Drug Saf."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/ene.14153","article-title":"Serious infections in patients with myasthenia gravis: population-based cohort study","volume":"27","author":"Kassardjian","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.anl.2018.10.004","article-title":"Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing","volume":"46","author":"Kumai","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front. Immunol."},{"key":"B20","volume-title":"Applied logistic regression","author":"Lemeshow","year":"2013"},{"key":"B21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/neurolint14020033","article-title":"Impact of COVID-19 in AChR myasthenia gravis and the safety of vaccines: Data from an Italian cohort","volume":"14","author":"Lupica","year":"2022","journal-title":"Neurol. Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious diseases society of America\/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MCP.0000000000000671","article-title":"Update in adult community-acquired pneumonia: Key points from the new American thoracic Society\/Infectious diseases society of America 2019 guideline","volume":"26","author":"Metlay","year":"2020","journal-title":"Curr. Opin. Pulm Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jnnp.2005.072355","article-title":"Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001","volume":"77","author":"Owe","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mus.26032","article-title":"Infections and the relationship to treatment in neuromuscular autoimmunity","volume":"57","author":"Prior","year":"2018","journal-title":"Muscle Nerve"},{"key":"B28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: An update","volume":"10","author":"Sheikh","year":"2021","journal-title":"J. Clin. Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116520","article-title":"Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: A retrospective national registry study","volume":"407","author":"Sipila","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \"seronegative\" myasthenia gravis\u2013a new role for an old antigen","volume":"292","author":"Stergiou","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/wnl.48.5.1253","article-title":"Myasthenic Crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"key":"B33","first-page":"286","article-title":"Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand","volume":"19","author":"Tiamkao","year":"2014","journal-title":"Neurosci. (Riyadh)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jemermed.2015.04.019","article-title":"Emergency department management of a myasthenia gravis patient with community-acquired pneumonia: Does initial antibiotic choice lead to cure or crisis","volume":"50","author":"Van Berkel","year":"2016","journal-title":"J. Emerg. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(21)00463-4","article-title":"Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders","volume":"21","author":"Verschuuren","year":"2022","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.nmd.2020.08.355","article-title":"Mortality rates and causes of death in Swedish myasthenia gravis patients","volume":"30","author":"Westerberg","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13054-020-03091-2","article-title":"Update of the treatment of nosocomial pneumonia in the ICU","volume":"24","author":"Zaragoza","year":"2020","journal-title":"Crit. Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12879-018-3276-5","article-title":"Rapid and precise diagnosis of disseminated T.marneffei infection assisted by high-throughput sequencing of multifarious specimens in a HIV-negative patient: A case report","volume":"18","author":"Zhu","year":"2018","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1016728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T07:45:35Z","timestamp":1670571935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1016728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":38,"alternative-id":["10.3389\/fcimb.2022.1016728"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1016728","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"article-number":"1016728"}}